{
    "title": "AstraZeneca says early trial data indicates third dose helps against Omicron",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10397651/New-data-finds-AstraZeneca-booster-generates-higher-antibodies-against-Omicron.html",
    "date": "2022-01-13",
    "keywords": [
        "vaccine",
        "vaxzevria",
        "booster",
        "trial",
        "shot",
        "astrazeneca",
        "omicron",
        "variant",
        "university",
        "mrna",
        "pushkala",
        "aripaka",
        "burger",
        "thursday",
        "blood",
        "analysis",
        "month",
        "technology",
        "biontechpfizer",
        "vaccination",
        "jan",
        "covid19",
        "increase",
        "response",
        "delta",
        "drugmaker",
        "data",
        "need",
        "httpswwwreuterscombusinesshealthcarepharmaceuticalswhyyoushouldstilltryavoidcatchingomicron20220112",
        "oxford",
        "lab",
        "course",
        "antibody",
        "statement",
        "potential",
        "shotcourse",
        "base",
        "company",
        "body",
        "evidence",
        "irrespective",
        "vector",
        "beta",
        "betaspecific",
        "half",
        "year",
        "work",
        "development",
        "upgrade",
        "december",
        "spread",
        "study",
        "time",
        "pfizer",
        "moderna",
        "boost",
        "contract",
        "bengaluru",
        "frankfurt",
        "editing",
        "sahu",
        "raissa",
        "kasolowsky"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}